MR-guided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: Preliminary results in 16 patients

European Journal of Radiology

Volumn 59, Issue 2, 2006, Pages 208-215

  Schwarzmaier, Hans Joachim ^a   Eickmeyer, Frank ^b   von Tempelhoff, Wernholt ^a   Fiedler, Volkhard Ulrich ^b   Niehoff, Hendrik ^a   Ulrich, Slif Dagobert ^b   Yang, Qin ^a   Ulrich, Frank ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Klinikum Krefeld   (Germany)

Author keywords

Interstitial thermotherapy; Laser induced thermocoagulation; MRI guided therapy; Recurrent glioblastoma multiforme; Survival

Indexed keywords

INTERSTITIAL THERMOTHERAPY; LASER-INDUCED THERMOCOAGULATION; MRI-GUIDED THERAPY; RECURRENT GLIOBLASTOMA MULTIFORME; SURVIVAL;

CHEMOTHERAPY; DISEASES; LASER BEAM EFFECTS; MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PATIENT TREATMENT;

DRUG THERAPY;

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HYPERTHERMIC THERAPY; LASER COAGULATION; LOW LEVEL LASER THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL TIME; THERMOCOAGULATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; LASER COAGULATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TEMPERATURE;

EID: 33746227573     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.05.010     Document Type: Article

References (28)

1. Brem H., Piantadosi S., Burger P.C., et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345 (1995) 1008-1012
2. Barker II F.G., Chang S.M., Gutin P.H., et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42 (1998) 709-720
3. Huncharek M., and Muscat J. Treatment of recurrent high grade astrocytomas: results of a systematic review of 1.415 patients. Anticancer Res 18 (1998) 1303-1312
4. Prados M.D., et al. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro-Oncol 6 (2004) 33-37
5. Wong E.T., Hess K.R., Gleason M.J., et al. Outcome and prognostic factors in recurrent gliomas patients enrolled onto phase II clinical trials. J Clin Oncol 17 8 (1999) 2572-2578
6. Brada M., Hoang-Xuan K., Rampling R., et al. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12 2 (2001) 259-266
7. Chua S.L., Rosenthal M.A., Wong S.S., et al. Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neuro-Oncol 6 1 (2004) 38-43
8. Kroll R.A., and Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42 (1998) 1083-1100
9. Everaert E., Neyns B., Joosens E., Strauven T., Branle F., and Menten J. Temozolomide for the treatement of recurrent supratentorial glioma: results of a compassionate use program in Belgium. J Neuro-Oncol 70 1 (2004) 37-48
10. Hall W.A., Djalilian H.R., Sperduto P.W., et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 13 (1995) 1642-1648
11. 125Iodine implants for recurrent malignant gliomas. Int J Oncol Biol Phys 43 (1999) 977-982
12. Florell R.C., MacDonald D.R., Irish W.D., et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76 (1992) 179-183
13. In: Westphal J., Tonn C.-J., and Ram Z. (Eds). Local therapies for gliomas: present status and future developments. Acta Neurochirurg Suppl 88 (2003)
14. Schwarzmaier H.-J., Tempelhoff W., Eickmeyer F., Fiedler V.U., Niehoff H., Ulrich S.D., et al. MR-guided laser irradiation of recurrent glioblastomas. J Magn Reson Imaging 22 6 (2005) 799-803
15. Kettenbach J., Silverman S.G., Hata N., Kuroda K., Saiviroonporn P., Zientara G.P., et al. Monitoring and visualization techniques for MR-guided laser ablations in an open MR system. J Magn Reson Imaging 8 4 (1998) 933-943
16. Schirmer T., Geoffroy Y., Koran S.J., and Ulrich F. Signa SP/2-a MRI system for image guided surgery. Med Laser Appl 17 (2002) 105-116
17. Kuroda K., Abe K., Tsutsumi S., Ishihara Y., Suzuki Y., and Satoh K. Water proton magnetic resonance sprctroscopy imaging. Biomed Thermol 13 (1994) 43-62
18. Botnar R.M., Steiner P., Dubno B., Erhart P., von Schulthess G.K., and Debatin J.F. Temperature quantification using the proton frequency shift technique: in vitro and in vivo validation in an open 0.5 T interventional MR scanner during RF Ablation. J Magn Reson Imaging 13 3 (2001) 437-444
19. Gering D.T., Nabavi A., Kikinis R., et al. An integrated visualization system for surgical planning and guidance using image fusion and an open MR. J Magn Reson Imaging 13 (2001) 967-975
20. Kahn T., Bettag M., Ulrich F., et al. MRI-guided laser-induced interstitial thermotherapy of cerebral neoplasms. J Comput Assist Tomogr 18 (1994) 519-532
21. Schwabe B., Kahn T., Harth T., Ulrich F., and Schwarzmaier H.-J. Laser-induced thermal lesions in the human brain: short and long term appearance on MRI. J Comput Assist Tomogr 21 (1997) 818-825
22. Schwarzmaier H.-J., Yaroslavsky I.V., Yaroslavsky A.N., Fiedler V., Ulrich F., and Kahn T. Treatment planning for MRI-guided laser-induced interstitial thermotherapy of brain tumors-the role of blood perfusion. J Magn Reson Imaging 8 (1998) 121-127
23. Reimer P., Bremer C., Horch C., and Morgenroth C. MR-monitored LITT as a palliative concept in patients with high grade gliomas: preliminary clinical experience. J Magn Reson Imaging 8 (1998) 240-244
24. Hata N., Morrison P.R., Kettenbach J., Black P.Mc.L., Kikinis R., and Jolesz F.A. Computer-assisted intra-operative magnetic resonance imaging monitoring of interstitial laser therapy in the brain: a case report. J Biomed Opt 3 (1998) 304-310
25. Brandes A.A., Brasso U., Reni M., et al. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. J Clin Oncol 22 9 (2004) 1598-1604
26. Goldberg S.N., Kamel I.R., Kruskal J.B., Reynolds K., Monsky W.L., Stuart K.E., et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 179 1 (2002) 93-101
27. Isbert C., Boerner A., Ritz J.P., Schuppan D., Buhr H.J., and Germer C.T. In situ ablation of experimental liver metastases delays and reduces residual intrahepatic tumor growth and peritoneal tumour spread compared with hepatic resection. Br J Surg 89 (2002) 1252-1259
28. Sabel M., Rommel F., Kondakei M., Gorol M., Willers R., and Bilzer T. Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermotherapy: a new concept of adjuvant glioma therapy?. Lasers Surg Med 33 (2003) 75-80